United Therapeutics shares fall after regulatory delays push back product launch

Shares of United Therapeutics fell more than 6 percent Monday after the company announced it would be delaying the launch of an implantable pump until 2018. The pump treats patients with pulmonary arterial hypertension, a type of high blood pressure that affects...

United Therapeutics shares fall after regulatory delays push back product launch

Shares of United Therapeutics fell more than 6 percent Monday after the company announced it would be delaying the launch of an implantable pump until 2018. The pump treats patients with pulmonary arterial hypertension, a type of high blood pressure that affects...